Effectiveness of Chlorhexidine oral decontamination in reducing the incidence of ventilator associated pneumonia: A meta-analysis.
British Journal of Medical Practitioners, 05/07/2012Balamurugan E et al.
The safety profile regarding the possible selection and induction of antibiotic resistance and presumed cost benefits of Chlorhexidine make it a highly attractive intervention for the prevention of Ventilator–associated pneumonia (VAP). This meta–analysis indicated that chlorhexidine can serve as a cost–effective and safe antiseptic in preventing VAP in mechanically ventilated patients.
An extensive literaturereview was conducted using the following databases: CINAHL, MEDLINE, Joanna Briggs Institute, Cochrane Library, EMBASE, CENTRAL, and the Google search engine.
Retrieved articles were selected based on the methodological quality, inclusion criteria and analysed to find the pooled effect size.
The nine trials included in this meta–analysis revealed a significant reduction in the incidence of VAP among patients who received prophylactic oral decontamination with Chlorhexidine.
However no significant effect was found in reducing overall mortality rate among the mechanically ventilated patients.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.